- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01709877
EndoCone Single Port Versus Conventional Multi-port Laparoscopic Approach
June 28, 2013 updated by: Franco Mosca, Azienda Ospedaliero, Universitaria Pisana
Randomised Non-inferiority Trial of Laparoscopic Cholecystectomy Performed With EndoCone Single Port Versus Conventional Multi-port Laparoscopic Approach Using Clinical, PROMS and Health Economic Endpoints
Its main objective is to evaluate the clinical outcome (including patient reported outcomes) and health economic assessment (HTA) of a new re-usable system for Single Port Laparoscopic Surgery - ENDOCONE SYSTEM developed by Prof Cuschieri by undertaking a randomised controlled prospective clinical trial (RCT) on specific operations performed (on a random allocation basis) by either the traditional multi-port laparoscopic approach or the Single Port- ENDOCONE system by Karl Storz.
To this effect, 300 patients meeting the trial inclusion criteria will be randomised over a three year period to have the operation by either of the two approaches.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Franco Mosca, Prof. MD
- Phone Number: +39 (0)50 996820
- Email: f.mosca@med.unipi.it
Study Contact Backup
- Name: Giovanni Caprili, MD
- Phone Number: +39 3286875111
- Email: mabcap@libero.it
Study Locations
-
-
AR
-
Arezzo, AR, Italy
- Not yet recruiting
- Ospedale San Donato
-
Contact:
- Fabio Sbrana, MD
-
-
LU
-
Lucca, LU, Italy
- Not yet recruiting
- Ospedale Campo di Marte
-
Contact:
- Andrea Carobbi, MD
-
-
PI
-
Pisa, PI, Italy, 56100
- Recruiting
- Ospedinale di Cisanello
-
Contact:
- Luca Morelli, MD
- Phone Number: +39 (0)50 996820
- Email: llmorelli74@hotmail.com
-
Pontedera, PI, Italy
- Not yet recruiting
- Ospedale Felice Lotti
-
Contact:
- Orlando Goletti, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with symptomatic gallstone disease
- ASA I/II
- Age between 18 and 80 years
Exclusion Criteria:
- ASA III or more
- significant co-morbid cardiovascular, neurological diseases, diabetics and chronic obstructive airway disease
- patients with previous history of invasive cancer
- patients with previous surgery
- patients requiring urgent/emergency interventions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Traditional multiport laparoscopic cholecystectomy
Standard laparoscopic cholecystectomy performed by the traditional multiport technique
|
Multiport and single-port laparoscopic cholecystectomy in patient with symptomatic gallstone disease
|
EXPERIMENTAL: Single port laparoscopic cholecystectomy
Laparoscopic cholecystectomy performed using the reusable ENDOCONE system with dedicated curved coaxial instruments
|
Multiport and single-port laparoscopic cholecystectomy in patient with symptomatic gallstone disease
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality
Time Frame: 30 days
|
30 days
|
|
Conversion rate
Time Frame: During the intervention
|
1 = if the intervention is converted to open surgery 0 = if the intervention is completed using standard laparoscopy or single port
|
During the intervention
|
Morbidity
Time Frame: 30 days
|
1 = if the patient has surgical complications 0 = no complications
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative course
Time Frame: 1 week
|
pain, measured using 1) visual linear analogue scale and 2) analgesic administration
|
1 week
|
Duration of hospital stay
Time Frame: 6 days
|
Date of the operation Date of hospital discharge
|
6 days
|
Return of bowel function
Time Frame: 12, 24, 48 hours
|
Passage of flatus and/or bowel motion
|
12, 24, 48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Franco Mosca, Prof, MD, AOUP
- Principal Investigator: Alfred Cuschieri, Prof, MD, Scuola Superiore Sant'Anna di Pisa
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (ANTICIPATED)
July 1, 2014
Study Completion (ANTICIPATED)
November 1, 2014
Study Registration Dates
First Submitted
October 17, 2012
First Submitted That Met QC Criteria
October 17, 2012
First Posted (ESTIMATE)
October 18, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
July 1, 2013
Last Update Submitted That Met QC Criteria
June 28, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AOUP_1
- RF-2009-1535329 (OTHER: Ministero della Salute - Direzione Generale della Ricerca Scientifica e Tecnologica; Regione Toscana)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gallstones
-
Mansoura UniversityCompletedCommon Bile Duct GallstonesEgypt
-
Minia UniversityCompletedGallstones Complicated by CBD StonesEgypt
-
Mansoura UniversityCompletedCommon Bile Duct GallstonesEgypt
-
Seoul National University HospitalUnknownCommon Bile Duct GallstonesKorea, Republic of
-
Hospital General Universitario de AlicanteInstituto de Salud Carlos IIINot yet recruitingAcute Pancreatitis Due to GallstonesSpain
-
Yonsei UniversityTerminatedGallbladder Polyp | Asymptomatic Gallstones Without CholecystitisKorea, Republic of
-
Air Force Military Medical University, ChinaCompletedCommon Bile Duct Gall Stones | Common Bile Duct GallStonesChina
-
Hospital Central "Dr. Ignacio Morones Prieto"CompletedAcute Pancreatitis Due to Gallstones
-
University of Sao Paulo General HospitalBoston Scientific CorporationUnknownCholedocholithiasis | Common Bile Duct GallstonesBrazil
-
University of CagliariUniversità di Napoli Federico II; Università della Campania Luigi VanvitelliNot yet recruitingAcute Pancreatitis | Pancreatitis Biliary | Pancreatitis Relapsing | Pancreatitis Due to GallstonesItaly
Clinical Trials on Cholecystectomy
-
Hospital Son LlatzerCompleted
-
University of AthensUnknownCholecystectomy, LaparoscopicGreece
-
Yale UniversityCompleted
-
Karolinska InstitutetCompleted
-
Maltepe UniversityCompleted
-
Natural Orifice Surgery Consortium for Assessment...American Society for Gastrointestinal EndoscopyUnknownGall Bladder DiseasesUnited States
-
University Hospital, GenevaUnknownCholecystitis | Symptomatic Gallbladder Stones | Biliary PancreatitisSwitzerland
-
Minia UniversityCompletedMorbid Obesity | GallstoneEgypt
-
South Valley UniversitySohag UniversityCompletedAcute Biliary Pancreatitis
-
University Hospital, GenevaCompletedGallbladder DiseaseSwitzerland